The National Institute of Allergy and Infectious Diseases invites applications for its research to advance hepatitis B virus cure – HIV/HBV co-infection and HBV mono-infection (R01 clinical trial not allowed) funding opportunity. This supports innovative basic, translational and clinical research to identify and address the challenges to achieving HBV cure in the presence or absence of HIV.
About R01 Research Project Grants.
Funding & Duration
Application budgets are not limited but need to reflect the actual needs of the project. The maximum grant period is five years
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Submission Requirements & Due Date
- Applications must be submitted for internal review by 22 January 2019
- Please email email@example.com if you are considering applying for this scheme.
- See also: Submitting an Application to Research Services for Review